These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 24457342)
41. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. Murray M; Hogg RS; Lima VD; May MT; Moore DM; Abgrall S; Bruyand M; D'Arminio Monforte A; Tural C; Gill MJ; Harris RJ; Reiss P; Justice A; Kirk O; Saag M; Smith CJ; Weber R; Rockstroh J; Khaykin P; Sterne JA; HIV Med; 2012 Feb; 13(2):89-97. PubMed ID: 21819529 [TBL] [Abstract][Full Text] [Related]
42. CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy. Okhai H; Vivancos-Gallego MJ; Hill T; Sabin CA AIDS Res Hum Retroviruses; 2020 Oct; 36(10):808-816. PubMed ID: 32664736 [TBL] [Abstract][Full Text] [Related]
43. Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression. Caby F; Guihot A; Lambert-Niclot S; Guiguet M; Boutolleau D; Agher R; Valantin MA; Tubiana R; Calvez V; Marcelin AG; Carcelain G; Autran B; Costagliola D; Katlama C Clin Infect Dis; 2016 May; 62(10):1297-1303. PubMed ID: 26908792 [TBL] [Abstract][Full Text] [Related]
51. Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients. Maskew M; Brennan AT; Westreich D; McNamara L; MacPhail AP; Fox MP J Womens Health (Larchmt); 2013 Feb; 22(2):113-20. PubMed ID: 23350862 [TBL] [Abstract][Full Text] [Related]
52. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. ; Lodwick RK; Sabin CA; Porter K; Ledergerber B; van Sighem A; Cozzi-Lepri A; Khaykin P; Mocroft A; Jacobson L; De Wit S; Obel N; Castagna A; Wasmuth JC; Gill J; Klein MB; Gange S; Riera M; Mussini C; Gutiérrez F; Touloumi G; Carrieri P; Guest JL; Brockmeyer NH; Phillips AN Lancet; 2010 Jul; 376(9738):340-5. PubMed ID: 20638118 [TBL] [Abstract][Full Text] [Related]
53. Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study. Shoko C; Chikobvu D; Bessong PO Pak J Biol Sci; 2020 Mar; 23(4):542-551. PubMed ID: 32363840 [TBL] [Abstract][Full Text] [Related]
54. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa. Fox MP; Sanne IM; Conradie F; Zeinecker J; Orrell C; Ive P; Rassool M; Dehlinger M; van der Horst C; McIntyre J; Wood R AIDS; 2010 Aug; 24(13):2041-50. PubMed ID: 20613459 [TBL] [Abstract][Full Text] [Related]
55. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Siegfried N; Uthman OA; Rutherford GW Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364 [TBL] [Abstract][Full Text] [Related]
57. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA; Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971 [TBL] [Abstract][Full Text] [Related]
58. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014. He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702 [TBL] [Abstract][Full Text] [Related]
59. CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV. Helleberg M; Kronborg G; Larsen CS; Pedersen G; Pedersen C; Obel N; Gerstoft J Clin Infect Dis; 2013 Jul; 57(2):314-21. PubMed ID: 23575194 [TBL] [Abstract][Full Text] [Related]
60. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients. Chow WZ; Lim SH; Ong LY; Yong YK; Takebe Y; Kamarulzaman A; Tee KK PLoS One; 2015; 10(9):e0137281. PubMed ID: 26335136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]